Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Oncotarget
|
December 5, 2014
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
Frank P Vendetti, Michael Topper, Peng Huang, et al.
The Journal of Infectious Diseases
|
February 24, 2012
CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA
Meir Shamay, Nicholas Hand, M Victor Lemas, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 6, 2013
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events
Brian Keeley, Alejandro Stark, Thomas R Pisanic, et al.
Science Advances
|
September 27, 2019
SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors
Akihiro Yoshida, Yiwen Bu, Shuo Qie, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2017
Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis
Daniel J Neitzke, Jacob S Bowers, Kristina Andrijauskaite, et al.
Nature Communications
|
July 14, 2025
Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway
Denggang Fu, Hua Jiang, Alan Long, et al.
The Annals of Thoracic Surgery
|
January 25, 2012
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer
Craig M Hooker, Robert A Meguid, Alicia Hulbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2016
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Alicia Hulbert, Ignacio Jusue-Torres, Alejandro Stark, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
Mark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Cancer Discovery
|
May 16, 2012
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer
Rosalyn A Juergens, John Wrangle, Frank P Vendetti, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Oncotarget
|
December 5, 2014
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
Frank P Vendetti, Michael Topper, Peng Huang, et al.
The Journal of Infectious Diseases
|
February 24, 2012
CpG methylation as a tool to characterize cell-free Kaposi sarcoma herpesvirus DNA
Meir Shamay, Nicholas Hand, M Victor Lemas, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
August 6, 2013
Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events
Brian Keeley, Alejandro Stark, Thomas R Pisanic, et al.
Science Advances
|
September 27, 2019
SLC36A1-mTORC1 signaling drives acquired resistance to CDK4/6 inhibitors
Akihiro Yoshida, Yiwen Bu, Shuo Qie, et al.
Cancer Immunology, Immunotherapy : CII
|
March 11, 2017
Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis
Daniel J Neitzke, Jacob S Bowers, Kristina Andrijauskaite, et al.
Nature Communications
|
July 14, 2025
Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway
Denggang Fu, Hua Jiang, Alan Long, et al.
The Annals of Thoracic Surgery
|
January 25, 2012
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer
Craig M Hooker, Robert A Meguid, Alicia Hulbert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2016
Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Alicia Hulbert, Ignacio Jusue-Torres, Alejandro Stark, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 1, 2022
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers
Mark P Rubinstein, Cameron Williams, Caroline Mart, et al.
Cancer Discovery
|
May 16, 2012
Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer
Rosalyn A Juergens, John Wrangle, Frank P Vendetti, et al.
Page
of 3